Health Products

Sandoz Glimepiride (2014-01-24)

· Published by Health Canada · Official notice

Details

Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type I
Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Products

Lot or serial numberCompaniesBrand nameDosage formDIN, NPN, DIN-HIMStrength
DM5336
Recalling Firm
Sandoz Canada Inc.
145 Jules-Léger
Boucherville
J4B 7K8
Quebec
CANADA
Marketing Authorization Holder
Sandoz Canada Inc.
145 Jules-Léger
Boucherville
J4B 7K8
Quebec
CANADA
B. Sandoz Glimepiride, 2 mgTabletDIN 022695972 mg
DM5336
Recalling Firm
Sandoz Canada Inc.
145 Jules-Léger
Boucherville
J4B 7K8
Quebec
CANADA
Marketing Authorization Holder
Sandoz Canada Inc.
145 Jules-Léger
Boucherville
J4B 7K8
Quebec
CANADA
A. Sandoz Glimepiride, 1 mgTabletDIN 022695891 mg

Introduction

Recalled products

A. Sandoz Glimepiride, 1 milligram (mg)

B. Sandoz Glimepiride, 2 mg

Reason

Recall initiated following the discovery of blisters of Sandoz Glimepiride 2 mg tablets, Lot DM5336, erroneously packaged in a box identified Sandoz Glimepiride 1 mg.  Therefore, units of this lot could be found in 1 mg or 2 mg inventories.

Depth of distribution

Wholesalers and pharmacies in Canada
Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime